Details for New Drug Application (NDA): 213358
✉ Email this page to a colleague
The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
Summary for 213358
Tradename: | TAMOXIFEN CITRATE |
Applicant: | Eugia Pharma |
Ingredient: | tamoxifen citrate |
Patents: | 0 |
Pharmacology for NDA: 213358
Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 213358
Suppliers and Packaging for NDA: 213358
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 213358 | ANDA | Aurobindo Pharma Limited | 59651-299 | 59651-299-60 | 60 TABLET, FILM COATED in 1 BOTTLE (59651-299-60) |
TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 213358 | ANDA | Aurobindo Pharma Limited | 59651-300 | 59651-300-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-300-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Aug 14, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Aug 14, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription